from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2651c/-

LFCtreatmentdescriptionclass of inhibitor

-0.414

Amikacinug/mL Amikacintranslation

-0.480

Cap5-10ug/mL Capreomycintranslation

-0.359

Rox10-50 ug/mL Roxithromycintranslation

-0.155

SM2-5 ug/mL Streptomycintranslation

0.443

Tet5-10 ug/mL Tetracyclinetranslation

-0.016

Rif0.2-5ug/mL Rifampicintranscription

-0.389

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.187

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.909

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.274

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.013

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.391

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.949

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.400

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.460

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.237

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.393

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.382

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.752

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.625

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.813

KCN5-20 ug/mL Potassium cyaniderespiration

-1.169

NaN30.2-2 mM Sodium aziderespiration

0.173

Nigericin50 uM Nigericinrespiration

0.053

TRC10-150 ug/mL Triclosanrespiration

0.802

TRZ10-25 ug/mL Thioridazinerespiration

4.517

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.871

menadione6-10 ug/mL Menadionerespiration

-0.327

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.473

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.243

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.472

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.375

NRP_1Non-replicating persistence stage 1dosRassociated

-0.452

Amp0.2mg/mL AmpicillincellWall

-0.172

Cephalexin20-100 ug/mL CephalexincellWall

0.035

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.179

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.649

EMB10-20 ug/mL EthambutolcellWall

-0.021

Eta12-40 ug/mL EthionamidecellWall

-0.391

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.417

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.713

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.214

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.160

BZA0.12 mg/mL BenzamidearomaticAmides

0.080

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.141

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.032

H2O24 mM hydrogen peroxideDNAdamaging

-0.475

Levo10 ug/mL LevofloxacinDNAdamaging

-0.319

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.023

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.037

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.369

UVUV-irradiationDNAdamaging

-0.752

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.541

Antimycin12.5-50 ug/mL Antimycin A?

-0.817

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.330

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.544

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.799

PA8240.2-2 ug/mL PA-824?

0.769

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.002

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.016

Verapamil50 uM Verapamil?

-0.548

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.646

methoxatin10-20 ug/mL Methoxatin?